| Literature DB >> 36087255 |
Julie Lafontaine1, Elena Refet-Mollof1,2, Ouafa Najyb1, Thomas Gervais1,2,3, Philip Wong4,5,6,7.
Abstract
Microfluidic technology facilitates the generation of 3D spheroids from cancer cells, a more suitable model for preclinical therapeutic studies. This system opens the possibility to test many drugs combination at a low cost. Here we describe the use of microfluidic devices for cytotoxicity evaluation on cancer spheroids for the discovery of drugs that could be used in combination with radiotherapy. Device fabrication, preparation, and seeding are also covered. Cell death arising following treatment is detected and characterized according to spheroid size, colony formation assays, and flow cytometry analysis of apoptotic marker annexin V.Entities:
Keywords: 3D culture; Annexin V; Chemotherapy; Clonogenic assay; Drug screening; ImageJ; Lab-on-chip; Microfluidic; Radiotherapy; Spheroids
Mesh:
Year: 2022 PMID: 36087255 DOI: 10.1007/978-1-0716-2553-8_2
Source DB: PubMed Journal: Methods Mol Biol ISSN: 1064-3745